Association driven by fewer major amputations ...

Medically reviewed by Jane Kim, MD Key Takeaways Metformin is the first choice medicine for type 2 diabetes. Meglitinides can ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

One of the most commonly known oral T2 diabetes drugs out there, it’s been around for over two decades now and is often referred to as the “first line of defence” in treating type 2 diabetes.

A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...

Older adults with type 2 diabetes newly treated with a GLP-1 receptor agonist had a lower risk for depression than DPP-4 inhibitor users. There was no difference for depression risk between new GLP-1 ...